GPP

Great Point Partners Portfolio holdings

AUM $154M
1-Year Return 2.36%
This Quarter Return
+14.87%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$341M
AUM Growth
+$78.9M
Cap. Flow
+$62.8M
Cap. Flow %
18.39%
Top 10 Hldgs %
70.61%
Holding
45
New
12
Increased
5
Reduced
12
Closed
5

Top Buys

1
DERM
Dermira, Inc.
DERM
$23.4M
2
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
$21.3M
3
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$20.6M
4
RXDX
Ignyta, Inc.
RXDX
$16M
5
ENTA icon
Enanta Pharmaceuticals
ENTA
$11.9M

Top Sells

1
FPRX
Five Prime Therapeutics, Inc.
FPRX
$23.4M
2
CMRX
Chimerix, Inc.
CMRX
$6.64M
3
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
$5.82M
4
EXEL icon
Exelixis
EXEL
$5.44M
5
VCEL icon
Vericel Corp
VCEL
$4.18M

Sector Composition

1 Healthcare 75.52%
2 Technology 2.73%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ADVM icon
26
Adverum Biotechnologies
ADVM
$66.5M
$1.74M 0.5%
55,012
-74,530
-58% -$2.35M
ASND icon
27
Ascendis Pharma
ASND
$12B
$1.02M 0.29%
+76,511
New +$1.02M
LSTA icon
28
Lisata Therapeutics
LSTA
$18.1M
$900K 0.26%
10,168
-1,236
-11% -$109K
PLXP
29
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$871K 0.25%
+10,989
New +$871K
VCEL icon
30
Vericel Corp
VCEL
$1.7B
$570K 0.16%
253,502
-1,857,236
-88% -$4.18M
PRTK
31
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$407K 0.12%
29,266
-276,193
-90% -$3.84M
SIOX
32
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$321K 0.09%
+3,125
New +$321K
RVNC
33
DELISTED
Revance Therapeutics, Inc.
RVNC
$295K 0.08%
+21,665
New +$295K
STRM
34
DELISTED
Streamline Health Solutions
STRM
$182K 0.05%
10,107
– –
RIGL icon
35
Rigel Pharmaceuticals
RIGL
$720M
$112K 0.03%
5,000
-10,787
-68% -$242K
ARDX icon
36
Ardelyx
ARDX
$1.58B
$30K 0.01%
+3,444
New +$30K
AMRN
37
Amarin Corp
AMRN
$311M
$4K ﹤0.01%
+100
New +$4K
ACAD icon
38
Acadia Pharmaceuticals
ACAD
$4.3B
– –
-100,000
Closed -$2.8M
MCRB icon
39
Seres Therapeutics
MCRB
$165M
– –
0
– –
SRPT icon
40
Sarepta Therapeutics
SRPT
$1.93B
– –
0
– –
ATYR
41
aTyr Pharma
ATYR
$536M
– –
-3,565
Closed -$197K
CMRX
42
DELISTED
Chimerix, Inc.
CMRX
– –
-1,300,000
Closed -$6.64M
ICPT
43
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
0
– –
FPRX
44
DELISTED
Five Prime Therapeutics, Inc.
FPRX
– –
-575,000
Closed -$23.4M
PTLA
45
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-50,000
Closed -$1.02M
1
2